Compass Financial Management’s Immix Biopharma IMMX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$62.4K Hold
6,000
– – 0.01% 693
2026
Q2
$56K Hold
6,000
– – 0.01% 671

Other funds holding IMMX

Compass Financial Management's IMMX Position: Q3 2026 in Review

Compass Financial Management held its Immix Biopharma (IMMX) position steady in Q3 2026 at 6,000 shares worth $62.4K. The position accounts for 0.01% of the portfolio, ranked #693.

Compass Financial Management first reported a position in IMMX in Q2 2026 and has held it in 2 quarters since. 136 funds tracked by Wall St. Rank hold IMMX as of Q3 2026.

  • Compass Financial Management held 6,000 shares of Immix Biopharma worth $62.4K as of Q3 2026.
  • Compass Financial Management left its Immix Biopharma share count unchanged in Q3 2026.
  • Immix Biopharma made up 0.01% of Compass Financial Management's portfolio in Q3 2026, its #693 holding.
  • Compass Financial Management first reported a position in Immix Biopharma in Q2 2026 and has held it in 2 quarters since.
  • 136 funds tracked by Wall St. Rank held Immix Biopharma as of Q3 2026.

Based on Compass Financial Management's 13F filing for Q3 2026, filed 30 Oct 2026.